In the August 2021 edition of Consumers Shaping Health, we announce the successful applicants for the Youth Health Incubator Grants, awarded to young people and youth health organisations with projects designed to...
The Primary Health Reform Steering Group was set up to advise the Government on developing the Primary Health Care 10 Year Plan. The Steering Group's discussion paper (...
On 25 February 2021, changes to the Therapeutic Goods (Medical Devices) Regulations 2002 (‘the Regulations’) commenced to introduce a new regulatory framework (the Framework) for medical devices that are designed and manufactured for individual patients (otherwise known as 'personalised' medical...
In the July 2021 edition of Consumers Shaping Health, we announce the commencement of Collaborative Pairs, a consumer leadership program with five pairs from across Australia and New Zealand.
The Therapeutic Goods Advertising Code (No.2) 2018 (the Code) is the compliance standard that prescribes the minimum requirements for the lawful advertising of therapeutic goods to the public in Australia. It is an important instrument for a range of stakeholders including advertisers,...
CHF submitted this response to the House of Representatives Standing Committee on Health, Aged Care and Sport inquiry into approval processes for new drugs and novel medical technologies in Australia June 2021.
The recommendations, which include feedback from health consumers who are...
2020-21 was an exciting year for CHF, from working with our growing member base to reach millions of consumers, to launching initiatives that will make a real difference to Australia's healthcare system....
In this edition of Consumers Shaping Health we ......
Our monthly newsletter Consumers Shaping Health will keep up to date with our activities and opportunities for you to be involved and have your say. You can choose to hear from us about new opportunities, events, webinars and more.